JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
24u
Huidig
Min
22.44
Max
24.33
Aanbevelingen | Buy |
---|---|
12 Maanden Prognose | +20.04% upside |
Volgende Winsten | 13 aug 2025 |
---|
By Acuity
50%
50%
162 / 374 Rangschikking in Healthcare
By Trading Central
Vertrouwen
Neutral Evidence
11.39 / 14.13 Steun & Weerstand
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
19 dec 2024, 15:25 UTC
Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding
DJ
Lezen
19 dec 2024, 13:38 UTC
Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead
DJ
Lezen
29 dec 2024, 08:00 UTC
Gilead Buys $20.1 Million of Assembly Biosciences Stock -- Barrons.com
DJ
Lezen
19 dec 2024, 13:23 UTC
Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead
DJ
Lezen
Prijswijziging
By TipRanks
12 Maanden Prognose
Gemiddelde 28.33 USD 20.04%
Hoogste 31 USD
Laagste 25 USD
Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Assembly Biosciences Inc - Dist. in de afgelopen 3 maanden.
By TipRanks
Buy
3 ratings
2
Buy
1
Hold
0
Sell
Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Assembly Biosciences Inc - Dist in de afgelopen 3 maanden.
By Trading Central
Korte Termijn
Neutral Evidence
The bullish and bearish events are balanced.
Gemiddeld Termijn
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Lange Termijn
Bearish Evidence
All events are bearish.
By Acuity
Nieuwssentiment
Neutral
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Boven gemiddelde
$